nGageIT Digital Health to attend HLTH Conference for Health Innovation
PRESS RELEASE: Toronto, Canada
nGageIT Digital Health will be attending HLTH Conference for Health Innovation October 27th through 30th, 2019 at MGM Grand, Las Vegas.
HLTH is a one-of-a-kind ecosystem event for the health industry, on a mission to bring together 5,000+ senior leaders to solve the most pressing problems facing healthcare today and actualize the most promising opportunities to improve health.
nGageIT is a world leader in developing rapid real time breath testing at the point of care based in Toronto. The company specialises in creating integrated real time rapid breath diagnostic test (RBDT) platforms for breath-based testing of cancer and inflammatory disease. The recipient of multiple awards for innovation, nGageITs all-in-one Airostotle ™ handheld devices make it easy to test and screen for a range of diseases such as cancer and chronic inflammatory diseases. Unlike standard, multi-component blood tests, Airostotle ™ platforms integrate features and deliver an easy to use non-invasive breath test with results in real time at the point of care without the need to ship out samples.
Early non-invasive detection of lung cancer, the leading cause of cancer-related death has tremendous societal and financial value. Lung cancer cells generate and out-gas unique volatiles that exit the body through breath, providing an olfactory signature. nGageIT is developing a breath analysis system that enables a completely non-invasive, low cost diagnosis of lung cancer. Using nGageIT’s Airostotle breath sensor system the company has completed a study showing high accuracy screening of lung cancer from breath compared to health patients. Further larger trials are planned to resolve sub-stratification of the disease.
As well as commercializing products in its own brand, nGageIT is developing strategic partnerships to provide OEM product development services to specialist diagnostic companies worldwide.